Akso Health Launches Patient Support Program and Partners with Nanning Duoling Research Institute.

Akso Health Group, a Nasdaq-listed company, has launched an exploratory patient support program in collaboration with Nanning Duoling Research Institute. The program aims to provide free in-hospital treatment plans for up to 10,000 eligible cancer patients through an integrated model of traditional Chinese medicine and modern medical technology. The program aims to address the urgent needs of cancer patients and reconstruct medical accessibility standards through global resource integration and zero-cost access.